EUVIMEDEUVIMED entdecken
Crossref

Impact of High-Intensity Statin on Atrial Fibrillation after Off-Pump Coronary Artery Bypass

Yeiwon Lee, Yoonjin Kang, Ji Seong Kim, Sue Hyun Kim, Suk Ho Sohn, Ho Young Hwang

The Thoracic and Cardiovascular Surgeon · 01.12.2025 · 73 (08) · 633-638

DOI: 10.1055/a-2447-0020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.12.2025. Verfasst von Yeiwon Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care, Seoul National University Hospital, Jongno-gu, Seoul, Korea. Hauptthemen laut MEDLINE: Atrial Fibrillation, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Coronary Artery Bypass, Off-Pump, Coronary Artery Disease. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is uncertainty regarding the impact of high-intensity statins on postoperative outcomes in patients undergoing surgical myocardial revascularization. This study was conducted to evaluate the impact of high-intensity statin treatment on the occurrence rate of new-onset postoperative atrial fibrillation (POAF) after off-pump coronary artery bypass grafting (OPCAB). Six hundred and thirteen patients (66.8 ± 9.8 years, male:female = 476:137) who underwent isolated OPCAB were retrospectively enrolled. Hypertension (n = 409, 66.7%), diabetes mellitus (n = 343, 59.6%), and chronic kidney disease (n = 138, 22.5%) were common comorbidities. Statins and beta-blockers were administered to all patients until the day of surgery and resumed within 6 hours after surgery. Risk factors associated with POAF were analyzed, including the use of high-intensity statins (atorvastatin 40–80 mg or rosuvastatin 20 mg), as well as baseline characteristics and preoperative risk factors. High-intensity statins were used in 158 patients (25.8%). POAF occurred in 184 patients (30.0%). The use of high-intensity statins was not correlated with preoperative levels of low-density lipoprotein (p = 0.446) or high-sensitivity C-reactive protein (p = 0.478). Multivariate logistic regression analysis revealed that the use of high-intensity statins was significantly associated with a reduced occurrence of POAF (p = 0.022, odds ratio [95% confidence interval] = 0.592 [0.378–0.926]). Age, acute coronary syndrome, insulin-dependent diabetes mellitus, and chronic kidney disease were also significantly associated with POAF. Preoperative administration of high-intensity statins was associated with a 41% reduction in the occurrence rate of POAF in patients who underwent OPCAB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHydroxymethylglutaryl-CoA Reductase InhibitorsCoronary Artery Bypass, Off-PumpCoronary Artery DiseaseAtorvastatinRosuvastatin CalciumHumansMaleFemaleRetrospective StudiesAgedRisk FactorsMiddle AgedTreatment OutcomeTime FactorsOdds RatioLogistic ModelsMultivariate AnalysisChi-Square Distribution

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsAtorvastatinRosuvastatin Calcium

Autor:innen und Institutionen

  • Department of Critical Care, Seoul National University Hospital, Jongno-gu, Seoul, Korea.
  • Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Jongno-gu, Seoul, Korea.

Zitieren

APA

Lee, Y., Kang, Y., Kim, J. S., Kim, S. H., Sohn, S. H., & Hwang, H. Y. (2025). Impact of High-Intensity Statin on Atrial Fibrillation after Off-Pump Coronary Artery Bypass. The Thoracic and Cardiovascular Surgeon, 73(08), 633-638. https://doi.org/10.1055/a-2447-0020

Vancouver

Lee Y, Kang Y, Kim JS, Kim SH, Sohn SH, Hwang HY. Impact of High-Intensity Statin on Atrial Fibrillation after Off-Pump Coronary Artery Bypass. The Thoracic and Cardiovascular Surgeon. 2025;73(08):633-638. doi:10.1055/a-2447-0020

BibTeX
@article{Lee2025,
  author = {Lee, Yeiwon and Kang, Yoonjin and Kim, Ji Seong and Kim, Sue Hyun and Sohn, Suk Ho and Hwang, Ho Young},
  title = {Impact of High-Intensity Statin on Atrial Fibrillation after Off-Pump Coronary Artery Bypass},
  journal = {The Thoracic and Cardiovascular Surgeon},
  year = {2025},
  volume = {73},
  number = {08},
  pages = {633--638},
  doi = {10.1055/a-2447-0020}
}
Kostenlos starten →